Publications by authors named "Suraj Konnath George"

7Publications

Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK T-cell lymphoma.

J Hematol Oncol 2019 07 24;12(1):80. Epub 2019 Jul 24.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Unit 072, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
July 2019

TrkA is a binding partner of NPM-ALK that promotes the survival of ALK T-cell lymphoma.

Mol Oncol 2017 09 18;11(9):1189-1207. Epub 2017 Jun 18.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
September 2017

Type I insulin-like growth factor receptor signaling in hematological malignancies.

Oncotarget 2017 Jan;8(1):1814-1844

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
January 2017

The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.

Oncotarget 2014 Jul;5(14):5750-63

Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX; The University of Texas Graduate School of Biomedical Sciences, Houston, TX.

View Article and Find Full Text PDF
July 2014